ambroxol in the therapy of the respiratory pathology among children
Clicks: 4
ID: 239198
2007
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
0.9
/100
4 views
3 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #109 of 111 articles by views in Biocontrol science
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
The article considers application peculiarities of halixomucolytic medication (Ambroxol, Egis, Hungary) to treat respiratory pathology among children. The author provides indications, contraindications, frequent therapeutic errors and intake peculiarities of the given medication among children.
Key words: ambroxol, respiratory diseases, children.
Key words: ambroxol, respiratory diseases, children.
| Reference Key |
simonova2007voprosyambroxol
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;O.I. Simonova |
| Journal | Biocontrol science |
| Year | 2007 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.